Skip to main content
. Author manuscript; available in PMC: 2016 Apr 1.
Published in final edited form as: Bone Marrow Transplant. 2015 Jan 26;50(4):493–498. doi: 10.1038/bmt.2014.302

Table 1. Patient Characteristics.

Characteristics TCD (N=52) Unmodified (N=115) p-value
Followup - survivors (months)* 38.9 (20.5-97.4) 47.9 (6.0,126.1) -

Age (years)* 40.4 (18.0-67.2) 34.0 (18.0,64.0) 0.176

>50 Years 13 (25.0) 18 (15.7) 0.221

Sex = Female 18 (34.6) 48 (41.7) 0.483

Time to CR1 (days)* 38.5 (7,180) 30 (14,210) 0.047

Time from CR1 (days) to HCT* (CR1 patients only) 109.0 (15.0,288.0) 101.0 (16.0,570.0) 0.787

Immunophenotype 0.099
T-Cell
WBC ≤ 50,000 3 (5.8) 10 (8.7)
WBC > 50,000 3 (5.8) 1 (0.9)
missing 1 (1.9) 1 (0.9)
B-Cell 0.102
WBC ≤ 30,000 25 (48.1) 53 (46.1)
WBC > 30,000 6 (11.5) 32 (27.8)
missing 4 (7.7) 18 (15.7)
Other 9 (17.3) -
missing 1 (1.9) -

Cytogenetic Risk 0.747
Good 1 (2.0) 5 (4.9)
Standard 29 (58.0) 61 (59.8)
Poor 20 (40.0) 36 (35.3)
missing 2 13

Donor Type <0.001
Matched Related 21 (40.4) 72 (62.6)
Matched Unrelated 15 (28.8) 42 (36.5)
Mismatch 16 (30.8) 1 (0.9)

Stem Cell Source 0.003
Bone Marrow 6 (11.5) 40 (34.8)
Peripheral Blood 46 (88.5) 75 (65.2)

TKI1 0.849
yes 5 (22.7) 13 (28.3)
no 17 (77.3) 33 (71.7)

CR Status
1st 36 (69.2) 60 (52.2) 0.058
2nd 16 (30.8) 55 (47.8)

ATG < 0.001
yes 39 (75.0) 29 (25.2)
no 13 (25.0) 86 (74.8)

TBI < 0.001
yes 47 (90.4) 62 (53.9)
no 5 (9.6) 53 (46.1)
*

Median(range)

1

Counts (percents) based on total po ssible individuals rec eiving TKI

Numeric variables tested via Wilcoxon Signed-Ranked Test

Categorical variables tested via Pearson's Chi-squared or Fisher's Exact Tests (excluding missing values) where appropriate.